Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug
Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug
Copy link
Eli Lilly’s orforglipron could offer needle-free alternative to weight-loss jabs at lower cost
Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose
The tablet - orforglipron - is available in the US and could soon launch in the UK.
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks.…
The pill doesn’t have the fasting requirements of many other weight loss drugs
An estimated 2.6 million people in the UK already use weight loss jabs to tackle stubborn fat. But for many the results can be…
